Amplicon mapping and transcriptional analysis pinpoint Cyclin L as a candidate oncogene in head and neck cancer

Cancer Research

Volumn 62, Issue 21, 2002, Pages 6211-6217

  Redon, Richard ^a   Hussenet, Thomas ^a   Bour, Gaétan ^a   Caulee, Krishna ^a   Jost, Bernard ^a   Muller, Danièle ^b   Abecassis, Joseph ^b   Du Manoir, Stanislas ^a  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b CENTRE PAUL STRAUSS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; COMPLEMENTARY DNA; CYCLIN L; GENE PRODUCT; INITIATION FACTOR 5A; PROTEIN P63; PROTEIN PIK3CA; UNCLASSIFIED DRUG;

AMPLICON; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CHROMOSOME 3Q; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA MICROARRAY; GENE AMPLIFICATION; GENE DELETION; GENE LOCATION; GENE MAPPING; GENE OVEREXPRESSION; GENETIC SCREENING; GENETIC TRANSCRIPTION; HEAD CANCER; HUMAN; HUMAN CELL; LUNG CANCER; NECK CANCER; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; UNINDEXED SEQUENCE; UTERINE CERVIX CANCER;

CARCINOMA, SQUAMOUS CELL; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 3; CYCLINS; HEAD AND NECK NEOPLASMS; HUMANS; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0036830160     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Kallioniemi, A., Kallioniemi, O-P., Sudar, D., Rutovitz, D., Gray, J. W., Waldman, F., and Pinkel, D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors, Science (Wash. DC), 258: 818-821, 1992.
2. Solinas-Toldo, S., Lampel, S., Stilgenbauer, S., Nickolenko, J., Benner, A., Dohner, H., Cremer, T., and Lichter, P. Matrix-based comparative genomic hybridization: Biochips to screen for genomic imbalances. Genes Chromosomes Cancer, 20: 399-407, 1997.
3. Pinkel, D., Segraves, R., Suda, R. D., Clark, S., Poole, I., Kowbel, D., Collins, C., Kuo, W. L., Chen, C., Zhai, Y., Dairkee, S. H., Ljung, B. M., Gray, J. W., and Albertson, D. G. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat. Genet., 20: 207-211, 1998.
4. Albertson, D. G., Ylstra, B., Segraves, R., Collins, C., Dairkee, S. H., Kowbel, D., Kuo, W. L., Gray, J. W., and Pinkel, D. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat. Genet., 25: 144-146, 2000.
5. Snijders, A. M., Nowak, N., Segraves, R., Blackwood, S., Brown, N., Conroy, J., Hamilton, G., Hindle, A. K., Huey, B., Kimura, K., Law, S., Myambo, K., Palmer, J., Ylstra, B., Yue, J. P., Gray, J. W., Jain, A. N., Pinkel, D., and Albertson, D. G. Assembly of microarrays for genome-wide measurement of DNA copy number. Nat. Genet., 29: 263-264, 2001.
6. Speicher, M. R., Howe, C., Crotty, P., du Manoir, S., Costa, J., and Ward, D. C. Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinomas. Cancer Res., 55: 1010-1013, 1995.
7. Bockmuhl, U., Schluns, K., Kuchler, I., Petersen, S., and Petersen, I. Genetic imbalances with impact on survival in head and neck cancer patients. Am. J. Pathol., 157: 369-375, 2000.
8. Redon, R., Muller, D., Caulee, K., Wanherdrick, K., Abecassis, J., and du Manoir, S. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains. Cancer Res., 61: 4122-4129, 2001.
9. Bockmuhl, U., Schluns, K., Schmidt, S., Matthias, S., and Petersen, I. Chromosomal alterations during metastasis, formation of head and neck squamous cell carcinoma. Genes Chromosomes Cancer, 33: 29-35, 2002.
10. Jiang, W., Kahn, S. M., Tomita, N., Zhang, Y. J., Lu, S. H., and Weinstein, I. B. Amplification and expression of the human cyclin D gene in esophageal cancer. Cancer Res., 52: 2980-2983, 1992.
11. Muller, D., Millon, R., Velten, M., Bronner, G., Jung, G., Engelmann, A., Flesch, H., Eber, M., Methlin, G., and Abecassis, J. Amplification of 11q13 DNA markers in head and neck squamous cell carcinomas: Correlation with clinical outcome. Eur. J. Cancer, 33: 2203-2210, 1997.
12. Gebhart, E., and Liehr, T. Patterns of genomic imbalances in human solid tumors (Review). Int. J. Oncol., 16: 383-399, 2000.
13. Shayesteh, L., Lu, Y., Kuo, W. L., Baldocchi, R., Godfrey, T., Collins, C., Pinkel, D., Powell, B., Mills, G. B., and Gray, J. W. PIK3CA is implicated as an oncogene in ovarian cancer. Nat. Genet., 21: 99-102, 1999.
14. Ma, Y. Y., Wei, S. J., Lin, Y. C., Lung, J. C., Chang, T. C., Whang-Peng, J., Liu, J. M., Yang, D. M., Yang, W. K., and Shen, C. Y. PIK3CA as an oncogene in cervical cancer. Oncogene, 19: 2739-2744, 2000.
15. Hibi, K. Trink, B., Patturajan, M., Westra, W. H., Caballero, O. L., Hill, D. E., Ratovitski, E. A., Jen, J., and Sidransky, D. AIS is an oncogene amplified in squamous cell carcinoma. Proc. Natl. Acad. Sci. USA, 97: 5462-5467, 2000.
16. Guan, X. Y., Sham, J. S., Tang, T. C., Fang, Y., Huo, K. K., and Yang, J. M. Isolation of a novel candidate oncogene within a frequently amplified region at 3q26 in ovarian cancer. Cancer Res., 61: 3806-3809, 2001.
17. Gioanni, J., Fischel, J. L., Lambert, J. C., Demard, F., Mazeau, C., Zanghellini, E., Ettore, F., Formento, P., Chauvel, P., Lalanne, C. M., and Courdi, A. Two new human tumor cell lines derived from squamous cell carcinomas of the tongue: establishment, characterization and response to cytotoxic treatment. Eur. J. Cancer Clin. Oncol., 24: 1445-1455, 1988.
18. Rangan, S. R. A new human cell line (FaDu) from a hypopharyngeal carcinoma. Cancer (Phila.), 29: 117-121, 1972.
19. Cheung, V. G., Nowak, N., Jang, W., Kirsch, I. R., Zhao, S., Chen, X. N., Furey, T. S., Kim, U. J., Kuo, W. L., Olivier, M. et al. Integration of cytogenetic landmarks into the draft sequence of the human genome. Nature (Lond.), 409: 953-958, 2001.
20. du Manoir, S., Schrock, E., Bentz, M., Speicher, M. R., Joos, S., Ried, T., Lichter, P., and Cremer, T. Quantitative analysis of comparative genomic hybridization. Cytometry, 19: 27-41, 1995.
21. International Human Genome Sequencing Consortium. Initial sequencing and analysis of the human genome. Nature (Lond.), 409: 860-921, 2001.
22. Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., et al. The sequence of the human genome. Science (Wash. DC), 291: 1304-1351, 2001.
23. Kanamori, A., Nakayama, J., Fukuda, M. N., Stallcup, W. B., Sasaki, K., Fukuda, M., and Hirabayashi, Y. Expression cloning and characterization of a cDNA encoding a novel membrane protein required for the formation of O-acetylated ganglioside: A putative acetyl-CoA transporter. Proc. Natl. Acad. Sci. USA, 94: 2897-2902, 1997.
24. Pegram, L. D., Megonigal, M. D., Lange, B. J., Nowell, P. C., Rowley, J. D., Rappaport, E. F., and Felix, C. A. t(3;11) translocation in treatment-related acute myeloid leukemia fuses MLL with the GMPS (guanosine 5-prime monophosphate synthetase) gene. Blood, 96: 4360-4362, 2000.
25. Hirst, M., Haliday, E., Nakamura, J., and Lou, L. Human GMP synthetase: Protein purification, cloning, and functional expression of cDNA. J. Biol. Chem., 269: 23830-23837, 1994.
26. van ‘t Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., Schreiber, G. J., Kerkhoven, R. M., Roberts, C., Linsley, P. S., Bernards, R., and Friend, S. H. Gene expression profiling predicts clinical outcome of breast cancer. Nature (Lond.), 415: 530-536, 2002.
27. Berke, J. D., Sgambato, V., Zhu, P. P., Lavoie, B., Vincent, M. Krause, M., and Hyman, S. E. Dopamine and glutamate induce distinct striatal splice forms of Ania-6, an RNA polymerase 11-associated cyclin. Neuron. 32: 277-287, 2001.
28. Guhaniyogi, J., and Brewer, G. Regulation of mRNA stability in mammalian cells. Gene (Amst.), 265: 11-23, 2001.
29. Herschman, H. R. Primary response genes induced by growth factors and tumor promoters. Annu. Rev. Biochem., 60: 281-319, 1991.
30. Iyer, V. R., Eisen, M. B., Ross, D. T., Schuler, G., Moore, T., Lee, J. C., Trent, J. M., Staudt, L. M., Hudson, J. J., Boguski, M. S., Lashkari, D., Shalon, D., Botstein, D., and Brown. P. O. The transcriptional program in the response of human fibroblasts to serum. Science (Wash. DC), 283: 83-87, 1999.
31. Monni, O., Barlund, M., Mousses, S., Kononen, J., Sauter, G., Heiskanen, M., Paavola, P., Avela, K., Chen, Y., Bittner, M. L., and Kallioniemi, A. Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer. Proc. Natl. Acad. Sci. USA, 98: 5711-5716, 2001.